The present invention provides: a novel antibody capable of binding to human CD3; or a molecule which is capable of binding to an antigen and contains the antibody.Provided are: a novel antibody capable of binding to human CD3; a molecule which contains the antibody and is capable of binding to an antigen; a pharmaceutical composition which contains the antibody or the molecule as an active ingredient and has a cytotoxic activity; and others.